Dose finding study for deciding the optimal dose of fluorescein during probe based confocal endomicroscopy
Phase 1
Recruiting
- Conditions
- gastrointestinal cancer
- Registration Number
- JPRN-UMIN000027696
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Not provided
Exclusion Criteria
Contraindication to biopsy. Patients who can not stop anticoagulants. Allergy to fluorescein. Patients who have the history of pheochromocytoma, malignant hypertension, severe heart failure, myocardial infarction that has occured with in 3 months, uncontrolled diabetes, severe pulmonary fibrosis, active interstitial pneumonia, uncontrolled infection. Pregnant. Others who are judged as inappropriate by medical doctors.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method